Study Finds Blood Plasma Can Restore Brain Function
Results from a new study show that brain function can be restored by human blood plasma.
Type 2 Diabetes Patients Have Higher Prevalence of Chronic Hepatitis B
A study has found that patients with type 2 diabetes have a higher prevalence of chronic hepatitis B virus infection.
VA Rule Expands Scope of Advanced-Practice Registered Nurses
The Veterans Affairs (VA) Department has issued a rule that will allow all advanced-practice registered nurses, with the exception of certified registered nurse anesthetists, to practice to their full authority at VA facilities.
Hemophilia B Gene Therapy Is Effective Despite Immune Reactions
A PhaseI/II study of nine patients with hemophilia B who underwent Spark Therapeutics’ SPK-9001 gene therapy are promising, despite two adverse autoimmune reactions.
Study Shows High Prevalence of Anti-TSH Receptor Antibody in Fibromyalgia
A study has found that patients with fibromyalgia have a high prevalence of anti-thyroid-stimulating hormone receptor antibody.
C.Diff Vaccine Shows Promise in Phase II Trial
Results of a Phase II clinical trial ofPfizer’s preventive vaccine againstClostridium difficile (C. diff) showed the vaccine was safe and stimulated a C. diff targeted immune response.
IVIG Treatment May Lead to Poorer Outcomes in GBS Patients
A new study shows that individuals treated with intravenous immune globulin (IVIG) for Guillain-Barré syndrome are at increased risk of developing hypoalbuminemia (reduced albumin levels).
CMS Rule Phases Out Pass-Through Payments
The Centers for Medicare andMedicaid Services has released the Use of New or Increased Pass Through Payments in Medicaid Managed Care final rule.
Alzheimer’s Could Be Detected Seven Years Prior to Symptoms
A new study shows that brains of people genetically inclined toward Alzheimer’s are likely to show abnormal immune reactions as early as seven years before the expected onset of the disease.
FDA Approves Gammaplex 10% to Treat Adult PI and ITP Patients
The U.S. Food and Drug Administration has approved Bio Products Laboratory’s Gammaplex 10% (immune globulin intravenous [human] 10% liquid) for the treatment of primary immunodeficiency (PI) and chronic immune thrombocytopenic purpura in adults.
